Establishing a link between the chemical composition and biological activities of Gladiolus italicus Mill. from the Turkish flora utilizing in vitro, in silico and network pharmacological methodologies
Özet
Objectives: Five solvent extracts (n-hexane, ethyl acetate, ethanol, ethanol/water (70%), and water) of Gladiolus italicus Mill. from Turkey were evaluated for chemical and biological properties. Methods: Antioxidant activities, inhibitory properties against key enzymes involved in the etiology of chronic diseases were tested, as well as cytotoxic effects on different cell lines. Chemical characterization was also carried out to determine the most abundant compounds of each extract. Results: The highest total phenolic content (TPC) was observed in the water extract while highest TFC in ethanol/water extract. The most abundant compounds in the extracts were hyperoside (69041.06 mg kg−1), isoquercitrin (46239.49 mg kg−1), delphindin-3,5-diglucoside (42043.81 mg kg−1), myricetin (21486.61 mg kg−1), and kaempferol-3-glucoside (21199.76 mg kg−1). Molecular dynamic (MD) simulations confirmed the structural stability and dynamic conformational integrity of these complexes over a period of 100 ns. In network pharmacology, A total of 657 unique target genes were screened: 52 associated with programmed cell death-1 (PD-1), 85 with vascular endothelial growth factor receptor-2 (VEGFR2), and 130 with fibroblast growth factor receptor-2 (FGFR2), identifying crucial gene interactions for these proteins. Gene ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway enrichment analyses were conducted, revealing significant interactions and pathways such as the advanced glycation end products (AGE) and their receptors (RAGE) signaling pathway in diabetic complications and T- helper 17 (Th17) cell differentiation, among others. This elucidation of complex networks involving key genes like AKT Serine/Threonine Kinase 1 (AKT1), MYC proto-oncogene (MYC), tumor protein 53 (TP53), Interleukin 6 (IL6), and tumor necrosis factor (TNF) provides a promising foundation for the development of targeted therapies in the treatment of non-communicable diseases. Conclusion: These results show that G. italicus could be a natural source of potent antioxidants and enzyme inhibitors which need to be further explored for the development of biopharmaceuticals.
Anahtar Kelimeler
- Scopus
- 15
- OpenAlex
- 13
Tam Kayıt
| Alan | Değer | Dil |
|---|---|---|
| dc.contributor.author | Zengin, Gokhan | |
| dc.contributor.author | Cetiz, Mehmet Veysi | |
| dc.contributor.author | Abul, Nurgul | |
| dc.contributor.author | Gulcin, Ilhami | |
| dc.contributor.author | Caprioli, Giovanni | |
| dc.contributor.author | Piatti, Diletta | |
| dc.contributor.author | Ricciutelli, Massimo | |
| dc.contributor.author | Koyuncu, Ismail | |
| dc.contributor.author | Yuksekdag, Ozgur | |
| dc.contributor.author | Bahşi, Muammer | |
| dc.contributor.author | Güler, Osman | |
| dc.contributor.author | Aumeeruddy, Muhammad Zakariyyah | |
| dc.contributor.author | Mahomoodally, Mohamad Fawzi | |
| dc.date.accessioned | 2026-10-28T14:55:02.803136003Z | |
| dc.date.available | 2026-10-28T14:55:02.803136003Z | |
| dc.date.issued | 2025 | |
| dc.description.abstract | Objectives: Five solvent extracts (n-hexane, ethyl acetate, ethanol, ethanol/water (70%), and water) of Gladiolus italicus Mill. from Turkey were evaluated for chemical and biological properties. Methods: Antioxidant activities, inhibitory properties against key enzymes involved in the etiology of chronic diseases were tested, as well as cytotoxic effects on different cell lines. Chemical characterization was also carried out to determine the most abundant compounds of each extract. Results: The highest total phenolic content (TPC) was observed in the water extract while highest TFC in ethanol/water extract. The most abundant compounds in the extracts were hyperoside (69041.06 mg kg−1), isoquercitrin (46239.49 mg kg−1), delphindin-3,5-diglucoside (42043.81 mg kg−1), myricetin (21486.61 mg kg−1), and kaempferol-3-glucoside (21199.76 mg kg−1). Molecular dynamic (MD) simulations confirmed the structural stability and dynamic conformational integrity of these complexes over a period of 100 ns. In network pharmacology, A total of 657 unique target genes were screened: 52 associated with programmed cell death-1 (PD-1), 85 with vascular endothelial growth factor receptor-2 (VEGFR2), and 130 with fibroblast growth factor receptor-2 (FGFR2), identifying crucial gene interactions for these proteins. Gene ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway enrichment analyses were conducted, revealing significant interactions and pathways such as the advanced glycation end products (AGE) and their receptors (RAGE) signaling pathway in diabetic complications and T- helper 17 (Th17) cell differentiation, among others. This elucidation of complex networks involving key genes like AKT Serine/Threonine Kinase 1 (AKT1), MYC proto-oncogene (MYC), tumor protein 53 (TP53), Interleukin 6 (IL6), and tumor necrosis factor (TNF) provides a promising foundation for the development of targeted therapies in the treatment of non-communicable diseases. Conclusion: These results show that G. italicus could be a natural source of potent antioxidants and enzyme inhibitors which need to be further explored for the development of biopharmaceuticals. | |
| dc.identifier.doi | 10.1080/15376516.2024.2397387 | |
| dc.identifier.eissn | 1537-6524 | |
| dc.identifier.endpage | 166 | |
| dc.identifier.issn | 1537-6516 | |
| dc.identifier.issue | 2 | |
| dc.identifier.pmid | 39246014 | |
| dc.identifier.scopus | 2-s2.0-85203374150 | |
| dc.identifier.startpage | 146 | |
| dc.identifier.uri | https://rdlopen.rawdatalibrary.net/r/munzur/2181 | |
| dc.identifier.volume | 35 | |
| dc.identifier.wos | WOS:001309214900001 | |
| dc.language.iso | en | |
| dc.publisher | Taylor and Francis Ltd. | |
| dc.relation.ispartof | Toxicology Mechanisms and Methods | |
| dc.rights | info:eu-repo/semantics/openAccess | |
| dc.subject | antioxidant | |
| dc.subject | enzyme inhibitors | |
| dc.subject | Gladiolus italicus | |
| dc.subject | hyperoside | |
| dc.subject | molecular dynamics | |
| dc.subject | network pharmacology | |
| dc.subject.other | Animals | |
| dc.subject.other | Antioxidants | |
| dc.subject.other | Cell Survival | |
| dc.subject.other | Computer Simulation | |
| dc.subject.other | Humans | |
| dc.subject.other | Molecular Docking Simulation | |
| dc.subject.other | Network Pharmacology | |
| dc.subject.other | Plant Extracts | |
| dc.subject.other | Turkey | |
| dc.subject.other | 1,1 diphenyl 2 picrylhydrazyl | |
| dc.subject.other | 2,2' azinobis(3 ethylbenzothiazoline 6 sulfonic acid) | |
| dc.subject.other | 3 hydroxybenzoic acid | |
| dc.subject.other | 3,5 dicaffeoylquinic acid | |
| dc.subject.other | 4 hydroxybenzoic acid | |
| dc.subject.other | acetic acid ethyl ester | |
| dc.subject.other | advanced glycation end product | |
| dc.subject.other | astragalin | |
| dc.subject.other | aurantiin | |
| dc.subject.other | chlorogenic acid | |
| dc.subject.other | cinnamic acid | |
| dc.subject.other | coumaric acid | |
| dc.subject.other | delphinidin | |
| dc.subject.other | ellagic acid | |
| dc.subject.other | ferulic acid | |
| dc.subject.other | fibroblast growth factor receptor 2 | |
| dc.subject.other | Gladiolus italicus extract | |
| dc.subject.other | hyperin | |
| dc.subject.other | interleukin 6 | |
| dc.subject.other | isoquercetin | |
| dc.subject.other | isorhamnetin | |
| dc.subject.other | kaempferol | |
| dc.subject.other | ligand | |
| dc.subject.other | myricetin | |
| dc.subject.other | phloretin | |
| dc.subject.other | phytochemical | |
| dc.subject.other | plant extract | |
| dc.subject.other | programmed death 1 receptor | |
| dc.subject.other | protein serine threonine kinase | |
| dc.subject.other | protein tyrosine kinase inhibitor | |
| dc.subject.other | quercetin | |
| dc.subject.other | rutoside | |
| dc.subject.other | tumor necrosis factor | |
| dc.subject.other | unclassified drug | |
| dc.subject.other | vasculotropin receptor 2 | |
| dc.subject.other | antioxidant | |
| dc.subject.other | antioxidant activity | |
| dc.subject.other | antioxidant assay | |
| dc.subject.other | apoptosis | |
| dc.subject.other | Article | |
| dc.subject.other | biological activity | |
| dc.subject.other | blood brain barrier | |
| dc.subject.other | cancer cell line | |
| dc.subject.other | cell differentiation | |
| dc.subject.other | cell viability assay | |
| dc.subject.other | chemical composition | |
| dc.subject.other | colorectal cancer | |
| dc.subject.other | computer model | |
| dc.subject.other | conformational transition | |
| dc.subject.other | controlled study | |
| dc.subject.other | cytotoxicity | |
| dc.subject.other | drug absorption | |
| dc.subject.other | drug distribution | |
| dc.subject.other | drug excretion | |
| dc.subject.other | drug metabolism | |
| dc.subject.other | drug targeting | |
| dc.subject.other | energy | |
| dc.subject.other | enzyme activity | |
| dc.subject.other | enzyme inhibition | |
| dc.subject.other | extraction | |
| dc.subject.other | flora | |
| dc.subject.other | gene interaction | |
| dc.subject.other | gene ontology | |
| dc.subject.other | Gladiolus | |
| dc.subject.other | high performance liquid chromatography | |
| dc.subject.other | human | |
| dc.subject.other | human cell | |
| dc.subject.other | in vitro study | |
| dc.subject.other | intestine absorption | |
| dc.subject.other | KEGG | |
| dc.subject.other | KG-1 cell line | |
| dc.subject.other | liver toxicity | |
| dc.subject.other | mass spectrometry | |
| dc.subject.other | melanoma | |
| dc.subject.other | methodology | |
| dc.subject.other | molecular docking | |
| dc.subject.other | molecular dynamics | |
| dc.subject.other | MTT assay | |
| dc.subject.other | nonhuman | |
| dc.subject.other | pathway enrichment analysis | |
| dc.subject.other | pharmacokinetic parameters | |
| dc.subject.other | Pi3K/Akt signaling | |
| dc.subject.other | prediction | |
| dc.subject.other | prostate cancer | |
| dc.subject.other | proto oncogene | |
| dc.subject.other | risk | |
| dc.subject.other | signal transduction | |
| dc.subject.other | systems pharmacology | |
| dc.subject.other | temperature | |
| dc.subject.other | Th17 cell | |
| dc.subject.other | Turkey (republic) | |
| dc.title | Establishing a link between the chemical composition and biological activities of Gladiolus italicus Mill. from the Turkish flora utilizing in vitro, in silico and network pharmacological methodologies | |
| dc.type | Article | |
| rdl.citation.openalex | 13 | |
| rdl.citation.scopus | 15 | |
| rdl.department | Department of Biology, Faculty of Science, Selcuk University, Konya, Turkey | |
| rdl.department | Department of Bioinformatics, Biozentrum der Universität Würzburg, Würzburg, Germany | |
| rdl.department | Department of Chemistry, Faculty of Sciences, Ataturk University, Erzurum | |
| rdl.department | CHemistry Interdisciplinary Project (CHip), School of Pharmacy, University of Camerino, Camerino, Italy | |
| rdl.department | Department of Medical Biochemistry, Faculty of Medicine, Harran University, Sanliurfa, Turkey | |
| rdl.department | Faculty of Education, Department of Primary Education, Firat University, Elazig, Turkey | |
| rdl.department | Pertek Sakine Genç Vocational School, Munzur University, Pertek, Tunceli, Turkey | |
| rdl.department | Department of Health Sciences, Faculty of Medicine and Health Sciences, University of Mauritius, Réduit, Mauritius | |
| rdl.department | Institute of Research and Development, Duy Tan University, Da Nang, Vietnam | |
| rdl.department | School of Engineering & Technology, Duy Tan University, Da Nang, Vietnam | |
| rdl.oa.status | green | |
| rdl.oa.status | closed | |
| rdl.oa.url | https://figshare.com/articles/journal_contribution/Establishing_a_link_between_the_chemical_composition_and_biological_activities_of_i_Gladiolus_italicus_i_Mill_from_the_Turkish_flora_utilizing_i_in_vitro_i_i_in_silico_i_and_network_pharmacological_methodologies/26968286 | |
| rdl.scopus.quartile | Q3 | |
| rdl.sdg | SDG03 | |
| rdl.source.index | SCOPUS | |
| rdl.source.index | WOS | |
| rdl.source.index | PUBMED |

